Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

44.71
Delayed Data
As of May 26
 +0.76 / +1.73%
Today’s Change
36.76
Today|||52-Week Range
45.84
+16.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues21.8B20.2B20.4B20.9B
 
 
 
 
 
Cost of Goods Sold9.1B8.2B8.0B8.3B
 
 
 
 
 
Depreciation And Amortization1.7B1.5B1.5B1.4B
 
 
 
 
 
 
Operating ExpensesGross Income11.0B10.5B11.0B11.2B
 
 
 
 
 
General Expenses8.3B7.6B8.0B8.0B
 
 
 
 
 
Research And Development1.5B1.3B1.4B1.4B
 
 
 
 
 
Total Operating Expenses19.1B17.3B17.5B17.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.7B2.9B2.9B3.2B
 
 
 
 
 
Extraordinary Credit0.000.0079.0M--
 
 
Extraordinary Charge-134.0M-346.0M-206.0M-112.0M
 
 
 
 
 
Interest Expense On Debt76.0M177.0M193.0M326.0M
 
 
 
 
 
Other Expenses-69.0M35.0M434.0M-1.5B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.5B2.5B3.2B1.4B
 
 
 
 
 
Income Taxes-138.0M-797.0M-577.0M-350.0M
 
 
 
 
 
Discontinued Operations193.0M563.0M65.0M321.0M
 
 
 
 
 
Extraordinary Items0.000.001.8B16.0M
 
 
 
Net Income2.6B2.3B2.7B1.4B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.6B1.5B1.5B1.5B
 
 
 
 
 
Shares To Calculate EPS Diluted1.6B1.5B1.5B1.5B
 
 
 
 
 
 
Earnings Per ShareEPS$1.62$1.49$2.92$0.94
 
 
 
 
 
EPS Diluted$1.63$1.49$1.76$0.93